GB0424871D0 - Antibodies and their use in therapy - Google Patents

Antibodies and their use in therapy

Info

Publication number
GB0424871D0
GB0424871D0 GB0424871A GB0424871A GB0424871D0 GB 0424871 D0 GB0424871 D0 GB 0424871D0 GB 0424871 A GB0424871 A GB 0424871A GB 0424871 A GB0424871 A GB 0424871A GB 0424871 D0 GB0424871 D0 GB 0424871D0
Authority
GB
United Kingdom
Prior art keywords
antibodies
therapy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0424871A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
UK Secretary of State for Environment Food and Rural Affairs
Original Assignee
UK Secretary of State for Environment Food and Rural Affairs
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by UK Secretary of State for Environment Food and Rural Affairs filed Critical UK Secretary of State for Environment Food and Rural Affairs
Priority to GB0424871A priority Critical patent/GB0424871D0/en
Publication of GB0424871D0 publication Critical patent/GB0424871D0/en
Ceased legal-status Critical Current

Links

GB0424871A 2004-11-11 2004-11-11 Antibodies and their use in therapy Ceased GB0424871D0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB0424871A GB0424871D0 (en) 2004-11-11 2004-11-11 Antibodies and their use in therapy

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0424871A GB0424871D0 (en) 2004-11-11 2004-11-11 Antibodies and their use in therapy

Publications (1)

Publication Number Publication Date
GB0424871D0 true GB0424871D0 (en) 2004-12-15

Family

ID=33523523

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0424871A Ceased GB0424871D0 (en) 2004-11-11 2004-11-11 Antibodies and their use in therapy

Country Status (1)

Country Link
GB (1) GB0424871D0 (en)

Similar Documents

Publication Publication Date Title
PL2287195T3 (en) Pan-kir2dl nk-receptor antibodies and their use in diagnostik and therapy
IL190332A0 (en) Human antibodies against il13 and therapeutic uses
IL182652A0 (en) Nitrobenzindoles and their use in cancer therapy
IL179476A0 (en) Antibodies against human interleukin-13 and uses therefor
IL172316A0 (en) Novel compounds and their use in therapy
IL183458A0 (en) Anti-il-1r1 single domain antibodies and therapeutic uses
TWI350286B (en) Alkylpiperazine- and alkylhomopiperazine-carboxylate derivatives, their preparation and their application in therapy
IL179140A0 (en) Antibody drug conjuates and methods
IL174994A0 (en) Pyrimidin - 4 - yl - 3, 4 - thione compounds and their use in therapy
IL178012A0 (en) Diphenyl-indol-2-on compounds and their use in the treatment of cancer
HK1081448A1 (en) Bispecific anti-erb-b antibodies and their use in tumor therapy
ZA200608100B (en) IRTA-5 antibodies and their uses
IL182554A0 (en) Anti-addl antibodies and uses thereof
GB0523576D0 (en) Drug composition and its use in therapy
EP1831194A4 (en) HETEROCYCLIC MCHr1 ANTAGONISTS AND THEIR USE IN THERAPY
ZA200703406B (en) Anti-ADDL antibodies and uses thereof
EP1838288A4 (en) Therapeutic materials and methods
GB0407382D0 (en) Therapeutic methods and means
SI1639013T1 (en) Pan-kir2dl NK-receptor antibodies and their use in diagnostic and therapy
HK1097495A1 (en) Can body and can
IL185575A0 (en) Benzoxazocines and their therapeutic use
ZA200802541B (en) Human antibodies against IL13 and therapeutic uses
GB0700827D0 (en) Hai-1 and Hai-2 in cancer therapy
GB0424871D0 (en) Antibodies and their use in therapy
GB0505908D0 (en) Antibodies and their use in therapy

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)